The influence of immunological stressors on traumatic brain injury

Research output: Contribution to journalReview ArticleResearchpeer-review

Abstract

Traumatic brain injury (TBI) is a leading cause of death and disability worldwide, and typically involves a robust immune response. Although a great deal of preclinical research has been conducted to identify an effective treatment, all phase III clinical trials have been unsuccessful to date. These translational shortcomings are in part due to a failure to recognize and account for the heterogeneity of TBI, including how extracranial factors can influence the aftermath of TBI. For example, most preclinical studies have utilized isolated TBI models in young adult males, while clinical trials typically involve highly heterogeneous patient populations (e.g., different mechanisms of injury, a range of ages, presence of polytrauma or infection). This paper will review the current, albeit limited literature related to how TBI is affected by common concomitant immunological stressors. In particular, discussion will focus on whether extracranial trauma (i.e., polytrauma), infection, and age/immunosenescence can influence TBI pathophysiology, and thereby may result in a different brain injury than what would have occurred in an isolated TBI. It is concluded that these immunological stressors are all likely to be TBI modifiers that should be further studied and could impact translational treatment strategies.

Original languageEnglish
Pages (from-to)618-628
Number of pages11
JournalBrain, Behavior, and Immunity
Volume69
DOIs
Publication statusPublished - 1 Mar 2018

Keywords

  • Age
  • Concussion
  • Immunosenescence
  • Infection
  • Inflammation
  • Polytrauma
  • Sepsis
  • Toxoplasma gondii

Cite this

@article{8325159418cd4125a91ace564a65be3b,
title = "The influence of immunological stressors on traumatic brain injury",
abstract = "Traumatic brain injury (TBI) is a leading cause of death and disability worldwide, and typically involves a robust immune response. Although a great deal of preclinical research has been conducted to identify an effective treatment, all phase III clinical trials have been unsuccessful to date. These translational shortcomings are in part due to a failure to recognize and account for the heterogeneity of TBI, including how extracranial factors can influence the aftermath of TBI. For example, most preclinical studies have utilized isolated TBI models in young adult males, while clinical trials typically involve highly heterogeneous patient populations (e.g., different mechanisms of injury, a range of ages, presence of polytrauma or infection). This paper will review the current, albeit limited literature related to how TBI is affected by common concomitant immunological stressors. In particular, discussion will focus on whether extracranial trauma (i.e., polytrauma), infection, and age/immunosenescence can influence TBI pathophysiology, and thereby may result in a different brain injury than what would have occurred in an isolated TBI. It is concluded that these immunological stressors are all likely to be TBI modifiers that should be further studied and could impact translational treatment strategies.",
keywords = "Age, Concussion, Immunosenescence, Infection, Inflammation, Polytrauma, Sepsis, Toxoplasma gondii",
author = "Mujun Sun and McDonald, {Stuart J.} and Brady, {Rhys D.} and O'Brien, {Terence J.} and Shultz, {Sandy R.}",
year = "2018",
month = "3",
day = "1",
doi = "10.1016/j.bbi.2018.01.007",
language = "English",
volume = "69",
pages = "618--628",
journal = "Brain, Behavior, and Immunity",
issn = "0889-1591",
publisher = "Mosby International",

}

The influence of immunological stressors on traumatic brain injury. / Sun, Mujun; McDonald, Stuart J.; Brady, Rhys D.; O'Brien, Terence J.; Shultz, Sandy R.

In: Brain, Behavior, and Immunity, Vol. 69, 01.03.2018, p. 618-628.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - The influence of immunological stressors on traumatic brain injury

AU - Sun, Mujun

AU - McDonald, Stuart J.

AU - Brady, Rhys D.

AU - O'Brien, Terence J.

AU - Shultz, Sandy R.

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Traumatic brain injury (TBI) is a leading cause of death and disability worldwide, and typically involves a robust immune response. Although a great deal of preclinical research has been conducted to identify an effective treatment, all phase III clinical trials have been unsuccessful to date. These translational shortcomings are in part due to a failure to recognize and account for the heterogeneity of TBI, including how extracranial factors can influence the aftermath of TBI. For example, most preclinical studies have utilized isolated TBI models in young adult males, while clinical trials typically involve highly heterogeneous patient populations (e.g., different mechanisms of injury, a range of ages, presence of polytrauma or infection). This paper will review the current, albeit limited literature related to how TBI is affected by common concomitant immunological stressors. In particular, discussion will focus on whether extracranial trauma (i.e., polytrauma), infection, and age/immunosenescence can influence TBI pathophysiology, and thereby may result in a different brain injury than what would have occurred in an isolated TBI. It is concluded that these immunological stressors are all likely to be TBI modifiers that should be further studied and could impact translational treatment strategies.

AB - Traumatic brain injury (TBI) is a leading cause of death and disability worldwide, and typically involves a robust immune response. Although a great deal of preclinical research has been conducted to identify an effective treatment, all phase III clinical trials have been unsuccessful to date. These translational shortcomings are in part due to a failure to recognize and account for the heterogeneity of TBI, including how extracranial factors can influence the aftermath of TBI. For example, most preclinical studies have utilized isolated TBI models in young adult males, while clinical trials typically involve highly heterogeneous patient populations (e.g., different mechanisms of injury, a range of ages, presence of polytrauma or infection). This paper will review the current, albeit limited literature related to how TBI is affected by common concomitant immunological stressors. In particular, discussion will focus on whether extracranial trauma (i.e., polytrauma), infection, and age/immunosenescence can influence TBI pathophysiology, and thereby may result in a different brain injury than what would have occurred in an isolated TBI. It is concluded that these immunological stressors are all likely to be TBI modifiers that should be further studied and could impact translational treatment strategies.

KW - Age

KW - Concussion

KW - Immunosenescence

KW - Infection

KW - Inflammation

KW - Polytrauma

KW - Sepsis

KW - Toxoplasma gondii

UR - http://www.scopus.com/inward/record.url?scp=85040767295&partnerID=8YFLogxK

U2 - 10.1016/j.bbi.2018.01.007

DO - 10.1016/j.bbi.2018.01.007

M3 - Review Article

VL - 69

SP - 618

EP - 628

JO - Brain, Behavior, and Immunity

JF - Brain, Behavior, and Immunity

SN - 0889-1591

ER -